Cited by 13Abdominal vascular conditions and treatmentsGastrointestinal Bleeding Diagnosis and TreatmentAppendicitis Diagnosis and Management

MDCT-findings in patients with non-occlusive mesenteric ischemia (NOMI): Influence of vasoconstrictor agents

Open access
Topolsky, Antoine, Pantet, Olivier, Liaudet, Lucas, Sempoux, Christine, Denys, Alban, Knebel, Jean-François, Schmidt, Sabine·2023·European Radiology

Abstract

OBJECTIVES: To evaluate the influence of vasoconstrictor agents (VCAs) on signs of vasoconstriction and bowel ischemia on MDCT detected in patients with non-occlusive mesenteric ischemia (NOMI). METHODS: This 8-year single-center retrospective study consecutively included all patients with histopathologically proven NOMI who underwent MDCT ≤ 48 h prior to surgical bowel resection. Two blinded radiologists jointly reviewed each examination for signs of bowel ischemia, abdominal organ infarct, mesenteric vessel size and regularity, and ancillary vascular findings. VCA administration (length and dosage), clinical and biochemical data, risk factors, and outcomes were retrieved from patients' medical records. Subgroup comparisons were performed. RESULTS: Ninety patients were included (59 males, mean age 65 years); 40 (44.4%) had received VCAs before MDCT. Overall mortality was 32% (n = 29), with no significant difference between the two groups. In patients treated with VCAs, the calibre of the superior mesenteric artery (SMA) was smaller (p = 0.032), and vasoconstriction of its branches tended to be more important (p = 0.096) than in patients not treated with VCAs. The presence and extent of bowel ischemia did not significantly correlate with VCA administration, but abdominal organ infarcts tended to be more frequent (p = 0.005) and involved more organs (p = 0.088). The VCA group had lower mean arterial pressure (p = 0.006) and lower hemoglobin levels (p < 0.001). Several biomarkers of organ failure and inflammation, differed significantly with VCA use, proving worse clinical condition. CONCLUSIONS: MDCT demonstrates more severe SMA vasoconstriction and tends to show increased abdominal organ infarcts after VCA administration in NOMI patients compared to NOMI patients not treated with VCAs. KEY POINTS: • In critically ill patients with NOMI, MDCT demonstrates VCA support via increased vasoconstriction of the main SMA and its branches. • VCA administration in NOMI patients tends to contribute to the development of organ infarcts, as shown on MDCT. • An important degree of vasoconstriction in NOMI patients may indicate insufficient resuscitation and, thus, help clinicians in further patient management.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00330-023-09415-4

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In critically ill patients with non-obstructive mesenteric ischemia, vasoconstricting agents can increase superior mesenteric artery vasoconstriction, potentially contributing to organ infarcts.

    “Furthermore, critically ill patients with non-obstructive mesenteric ischemia prescribed vasoconstricting agents can increase superior mesenteric artery vasoconstriction, potentially contributing to organ infarcts [17].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Topolsky, A., Pantet, O., Liaudet, L., Sempoux, C., Denys, A., Knebel, J.-F., & Schmidt, S.
Affiliations
Centre Hospitalier Universitaire Vaudois (CH)
Corresponding author
Schmidt, Sabine
Venue
European Radiology
Published
2023-01-24
Volume
33
Issue
5
Pages
3627-3637
ISSN
  • 0938-7994 (ISSN-L)
  • 1432-1084
OpenAlex
W4317869811
Cited by
13
References
26
Citations by year
2026: 5 · 2025: 2 · 2024: 5 · 2023: 1
FWCI
3.47
Type
journal article
Language
en
Open access
Locations
  • European Radiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion, cc-by)
  • IRIS (submittedVersion, cc-by)
Funders
University of Lausanne
Topics
  • Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
  • Health Sciences › Medicine › Emergency Medicine › Appendicitis Diagnosis and Management
Keywords
nonocclusive mesenteric ischemia, vasoconstrictors, multidetector computed tomography, intestinal ischemia, critically ill patients, mortality, hemodynamic instability, mean arterial pressure
MeSH terms
Aged, Humans, Infarction, Ischemia, Male, Retrospective Studies, Tomography, X-Ray Computed, Vasoconstrictor Agents, Mesenteric Ischemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review